Found 8 matching trials
Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome
PHASE2This is a multicenter, single arm open label Phase 2b Study of oral ezatios...
Location
Bay Area Cancer Research Group
Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
PHASE2This is a randomized, open label, multicenter, Phase 2 study comparing two ...
Location
Arizona Cancer Center
Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
PHASE1The purpose of this study is to determine the safety and efficacy of TLK199...
Location
University of Alabama at Birmingham
Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome
PHASE2Study TLK199.2107 is a multicenter, single arm, open-label Phase 2 study of...
Location
Loyola University
Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
PHASE1The purpose of this study is to determine the safety and efficacy of TLK199...
Location
Loyola University Chicago-Cardinal Bernardin Cancer Center
Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
PHASE1This is an open label, multicenter Phase 1 dose escalation study evaluating...
Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer
PHASE2TLK199.2102 was a multicenter Phase 2 randomized study to determine the eff...
Location
Central Hematology Oncology Medical Group
Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
PHASE2This is a multicenter Phase 2 randomized parallel-group study to determine ...
Location
Center for Cancer and Blood Disorders